Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Chondroitin sulfate + glucosamine hydrochloride** is a combination dietary supplement commonly used to alleviate symptoms of osteoarthritis, particularly joint pain and stiffness. Both chondroitin sulfate and glucosamine hydrochloride are naturally occurring substances found in cartilage and connective tissue. Theoretically, they are believed to have *anti-inflammatory* and *chondroprotective* effects, possibly slowing cartilage breakdown and promoting cartilage repair. Glucosamine promotes glycosaminoglycan synthesis, a key cartilage component, while chondroitin provides resistance to compression in cartilage. The combination is widely studied, with mixed results regarding efficacy. Some studies suggest benefits in osteoarthritis (notably for moderate to severe knee pain), though overall outcomes are often comparable to placebo. This supplement is not FDA-approved as a pharmaceutical and is marketed as a nutraceutical product or dietary supplement[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chondroitin sulfate + glucosamine hydrochloride.